Trial · NCT07888842
A Clinical Study on Systemic Sclerosis and the Validation of French-language Questionnaires Assessing Disability, Quality of Life, and Disease Status.
NCT07888842, Not yet recruiting, Assistance Publique - Hôpitaux de Paris
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Clinical Study on Systemic Sclerosis and the Validation of French-language Questionnaires Assessing Disability, Quality of Life, and Disease Status. Trials, record NCT07888842. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888842
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Clinical Study on Systemic Sclerosis and the Validation of French-language Questionnaires Assessing Disability, Quality of Life, and Disease Status.
- NCT number
- NCT07888842
- Status
- Not yet recruiting
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Conditions
- Scleroderma
- Interventions
- Questionnaires
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | CSF 17 (Cochin 17-item Scleroderma Functional scale) | Day 0 | Questionnaire developed by the internal medicine department's research group for the SCISCIF studies to assess the patient's self-perceived health. The aim of this study is to validate French-language disability questionnaires for this patient population. |
| Primary | CSF 17 (Cochin 17-item Scleroderma Functional scale) | Month 3 | Questionnaire developed by the internal medicine department's research group for the SCISCIF studies to assess the patient's self-perceived health. The aim of this study is to validate French-language disability questionnaires for this patient population. |
| Primary | ScleroID questionnaire | Day 0 | Disability questionnaire, a scale requiring validation designed to assess global functional impairment associated with SSc |
| Primary | ScleroID questionnaire | Month 3 | Disability questionnaire, a scale requiring validation designed to assess global functional impairment associated with SSc |
| Primary | SSPRO | Day 0 | Patient-reported assessment questionnaire; scale requiring validation, assessing the patient's evaluation of their disease. |
| Primary | SSPRO | Month 3 | Patient-reported assessment questionnaire; scale requiring validation, assessing the patient's evaluation of their disease. |
| Primary | HAQ-DI questionnaire | Day 0 | Scales for measuring functional disability in SSc |
| Primary | HAQ-DI questionnaire | Month 3 | Scales for measuring functional disability in SSc |
| Primary | SHAQ questionnaire | Day 0 | Scales for measuring functional disability in SSc |
| Primary | SHAQ questionnaire | Month 3 | Scales for measuring functional disability in SSc |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888842
GET https://conductscience.org/api/trials/v1/NCT07888842/registered